샘플 요청 목록

 카트 문의
시장보고서
상품코드
1770161

세계의 합성생물학 시장

Synthetic Biology
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 442 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

합성생물학 세계 시장은 2030년까지 862억 달러에 달할 전망

2024년에 197억 달러로 추정되는 합성생물학 세계 시장은 2024-2030년 분석 기간 동안 CAGR 27.9%로 성장하여 2030년에는 862억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 올리고뉴클레오티드·합성 DNA는 CAGR 29.1%를 기록하며 분석 기간 종료까지 395억 달러에 달할 것으로 예상됩니다. 효소 분야의 성장률은 분석 기간 동안 CAGR 26.8%로 추정됩니다.

미국 시장은 69억 달러로 추정되는 한편 중국은 CAGR 32.0%로 성장할 것으로 예측되는

미국의 합성생물학 시장은 2024년에 69억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 32.0%를 기록하며 2030년까지 89억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 25.7%와 26.6%로 예측됩니다. 유럽에서는 독일이 CAGR 28.6%로 성장할 것으로 예측됩니다.

세계의 합성생물학 시장 - 주요 동향과 촉진요인 정리

합성생물학은 공학, 생물학, 화학, 컴퓨터과학, 유전학의 원리를 결합하여 새로운 생물학적 부품, 장치, 시스템을 설계하고 구축하는 다학제적 과학의 한 분야입니다. 이 분야는 기존의 자연 생물학적 시스템을 유용한 목적으로 재설계하여 원하는 기능을 가진 새로운 생물을 공학적으로 설계하는 것을 목적으로 합니다. 그 핵심인 합성생물학에서는 유전물질을 합성하여 자연계에 존재하지 않는 DNA 염기서열을 만들고, 이를 이용하여 생물이 특정 작업을 수행하도록 프로그래밍합니다. 그 응용 범위는 바이오연료와 의약품 생산, 신소재의 창제, 생물학적 정보 처리까지 다양합니다.

합성생물학 분야는 CRISPR-Cas9와 같은 유전공학 기술의 발전으로 유전체 편집의 정확성, 효율성, 가격이 비약적으로 향상되어 큰 진전을 이루었습니다. 또한, 합성생물학은 유전자 변이의 대량 합성 및 테스트를 가능하게 하는 자동화된 컴퓨터 지원 기술에 의존하는 경우가 많습니다. 이러한 능력은 건강, 에너지, 환경 관리와 같은 문제에 대한 생물학적 해결책의 개발을 빠르게 발전시킬 수 있습니다. 예를 들어, 합성생물학자들은 말라리아 치료제인 아르테미시닌과 같은 복잡한 약물을 생산할 수 있는 효모 세포와 플라스틱을 분해하여 환경 친화적인 제품으로 바꿀 수 있는 박테리아를 조작해 왔습니다. 인공지능과 기계학습과 합성생물학의 융합 또한 새로운 발견과 응용을 통해 실현 가능한 것의 한계를 더욱 넓힐 수 있는 잠재력을 가지고 있습니다.

합성생물학 시장의 성장은 다양한 산업 분야에서 지속가능한 솔루션에 대한 수요 증가, 생명공학 응용 확대, 연구개발에 대한 막대한 투자 등 여러 요인에 의해 주도되고 있습니다. 환경 문제에 대한 우려와 지속가능한 생산 방법에 대한 필요성이 바이오 기반 화학제품, 재료 및 연료 개발에 합성생물학의 사용을 촉진하고 있습니다. 이러한 접근 방식은 생태 발자국을 줄이는 데 도움이 될 뿐만 아니라 화석 연료에 대한 의존도를 낮추는 데에도 도움이 될 수 있습니다. 제약 분야에서는 전통적인 신약 개발 프로세스는 시간과 비용이 많이 들기 때문에 보다 효과적인 새로운 치료법을 개발하기 위해 합성생물학 기술이 활용되고 있습니다. 또한, 생명공학의 발전을 지원하는 정책적 프레임워크와 다학제적 과학에 능통한 인력의 증가도 시장을 촉진하고 있습니다. 벤처 캐피털의 자금 지원과 정부 보조금과 같은 경제적 요인도 이 분야에 지속적으로 자금을 투입하고 있으며, 혁신적인 스타트업의 창업과 바이오테크놀러지 솔루션의 규모 확장을 촉진하고 있습니다. 이처럼 합성생물학이 재료, 화학제품, 의약품 개발 방식을 변화시키고 효율성, 비용, 성능을 크게 향상시킴에 따라 합성생물학 시장은 강력한 성장이 예상됩니다.

부문

툴(올리고뉴클레오티드·합성 DNA, 효소, 클로닝 기술 키트, 합성 세포, 제노 핵산(XNA), 섀시 생물), 기술(뉴클레오티드 합성·시퀀싱, 유전체 공학, 마이크로플루이딕스, 기타 기술), 용도(의약품·진단, 산업, 식품·농업, 환경, 기타 용도)

조사 대상 기업 사례

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Agrivida, Inc.
  • ATG Biosynthetics GmbH
  • Algentech SAS
  • Arzeda
  • AdvanceSyn
  • Asimov, Inc.
  • ArsenalBio
  • Abiochem Biotechnology
  • Accelerbiotics
  • Antheia
  • Ardra Bio
  • Baccuico
  • Absci Corp.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.07.23

Global Synthetic Biology Market to Reach US$86.2 Billion by 2030

The global market for Synthetic Biology estimated at US$19.7 Billion in the year 2024, is expected to reach US$86.2 Billion by 2030, growing at a CAGR of 27.9% over the analysis period 2024-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$39.5 Billion by the end of the analysis period. Growth in the Enzymes segment is estimated at 26.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 32.0% CAGR

The Synthetic Biology market in the U.S. is estimated at US$6.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2030 trailing a CAGR of 32.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.7% and 26.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.6% CAGR.

Global Synthetic Biology Market - Key Trends & Drivers Summarized

Synthetic biology is an interdisciplinary branch of science that combines principles from engineering, biology, chemistry, computer science, and genetics to design and construct new biological parts, devices, and systems. This field aims to redesign existing natural biological systems for useful purposes and to engineer novel organisms with desired functions. At its core, synthetic biology involves the synthesis of genetic material to create DNA sequences that do not exist in the natural world, which are then used to program organisms to perform specific tasks. Applications range from producing biofuels and pharmaceuticals to creating new materials and processing information biologically.

The field of synthetic biology has made significant strides thanks to advancements in genetic engineering techniques such as CRISPR-Cas9, which have dramatically increased the precision, efficiency, and affordability of genome editing. Moreover, synthetic biology often relies on automated and computer-assisted techniques that allow for the high-throughput synthesis and testing of genetic variations. These capabilities facilitate rapid progress in developing biological solutions to issues in health, energy, and environmental management. For instance, synthetic biologists have engineered yeast cells that can produce complex drugs, like artemisinin for malaria treatment, and bacteria that can break down plastics into environmentally benign byproducts. The integration of artificial intelligence and machine learning with synthetic biology also holds the potential to unlock new discoveries and applications, further pushing the boundaries of what can be achieved.

The growth in the synthetic biology market is driven by several factors, including the increasing demand for sustainable solutions across various industries, the expansion of biotechnology applications, and significant investment in research and development. Environmental concerns and the need for sustainable production methods propel the use of synthetic biology in developing bio-based chemicals, materials, and fuels. This approach not only helps in reducing the ecological footprint but also in diminishing dependence on fossil fuels. In the pharmaceutical sector, synthetic biology techniques are being used to produce new and more effective therapies, especially as traditional drug discovery processes prove to be time-consuming and costly. The market is also bolstered by policy frameworks that support biotechnological advancements and by a growing workforce skilled in interdisciplinary sciences. Economic factors, including venture capital funding and governmental grants, continue to inject financial resources into the field, promoting innovative startups and scaling up of bio-engineered solutions. As such, the market is expected to see robust growth as synthetic biology transforms how materials, chemicals, and drugs are developed, offering vast improvements in efficiency, cost, and performance.

SCOPE OF STUDY:

The report analyzes the Synthetic Biology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Tool (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA), Chassis Organism); Technology (Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics, Other Technologies); Application (Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 141 Featured) -

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Agrivida, Inc.
  • ATG Biosynthetics GmbH
  • Algentech SAS
  • Arzeda
  • AdvanceSyn
  • Asimov, Inc.
  • ArsenalBio
  • Abiochem Biotechnology
  • Accelerbiotics
  • Antheia
  • Ardra Bio
  • Baccuico
  • Absci Corp.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Synthetic Biology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Synthetic Biology - A New Interdisciplinary Field
    • Growing Importance of Synthetic Biology
    • Applications of Synthetic Biology
    • Synthetic Biology Tools
    • Technologies Involved
    • Market Outlook
    • Regional Landscape
    • Major Challenges and Concerns
    • Teaming R&D Funding & Potential to Alter Molecular Landscape Enable Global Synthetic Biology Market to Remain in High Spirits
    • Synthetic Biology to Radically Change the World for Good with Endless Applications
    • Competitive Landscape
    • Major Players by Industry Verticals
    • Select Market Participants
    • Synthetic Biology Startups Get Aggressive on Bioengineered Product Commercialization
    • Compelling Breakthroughs Drive Funding
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Synthetic Biology Market Witnesses Significant Rise in Investments
    • Importance of Synthetic Biology for Investments
    • Efforts from Leading Players Bodes Well for Market Growth
    • Patent Landscape Gets Richer
    • Robotics and Workflow Automation Support Market Expansion
    • Advancements in Instrumentation Augurs Well
    • Improvements in Computer-Aided Biology
    • Fusion of AI and Synthetic Biology Expands Opportunities
    • Synthetic Biology Brings a Paradigm Shift in the Field of Biological Research
    • DNA Sequencing Plays an Important Role
    • Plummeting Cost of DNA Sequencing Bolsters Market Growth
    • Food Scarcity to Fuel Synthetic Biology Application in Agriculture
    • Select Companies Engaged in Making Food Using Synthetic Biology
    • Synthetic Biology Aids in Development of Exotic and Artificially Grown Meats and Proteins to Meet Future Food Demand
    • Growing Demand for GM Crops Opens Up Growth Avenues
    • Synthetic Biology-based Ingredients Gain Traction
    • Role of Synthetic Biology in Producing Plants with Desirable Characteristics
    • Synthetic Biology Gains Prominence in Biomedical Applications
    • Synthetic Genes Open up a New World of Drug Development
    • Synthetic Biology to Transform Healthcare with Captivating Advances in Biomedicine
    • Synthetic Biology Enables Creation of Advanced Biosensing Systems
    • Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and Biofuels
    • Global Biofuels Market in US$ Billion: 2019 and 2024
    • Synthetic Biology Gains Importance as Focus on Carbon Recycling Increases
    • Synthetic Biology Disrupts the Cosmetics Sector
    • Capability of Synthetic Biology in Environmental Applications
    • Synthetic Biology Creates Buzz as Key Enabler of Exciting & Dynamic Applications for Diverse Domains
    • Synthetic Biology for Advanced, Multifunctional Materials
    • Genetically Engineered Fabrics and Sustainable Dyes Using Synthetic Biology to Transform Textile Industry
    • Select Synthetic Biology Offerings in Textile Industry
    • Personalized Medicine to Display Notable Leap Forward with Synthetic Biology
    • 3D Bio-Printing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Synthetic Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Oligonucleotides & Synthetic DNA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Oligonucleotides & Synthetic DNA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Oligonucleotides & Synthetic DNA by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cloning Technology Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cloning Technology Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cloning Technology Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Synthetic Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Synthetic Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Synthetic Cells by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Xeno-Nucleic Acids (XNA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Xeno-Nucleic Acids (XNA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Xeno-Nucleic Acids (XNA) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Chassis Organism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Chassis Organism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Chassis Organism by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Nucleotide Synthesis & Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Nucleotide Synthesis & Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Nucleotide Synthesis & Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Genome Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Genome Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Genome Engineering by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Pharmaceuticals & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Pharmaceuticals & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Food & Agriculture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 45: World 15-Year Perspective for Environmental by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 48: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 49: World Synthetic Biology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Synthetic Biology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of World 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of World 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제